Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012

Oncology Clinical Development Congress

10 Oct 2012 - 11 Oct 2012 - Manchester, UK

Bookmark and Share

The global oncology market faces the dual problem of increasing drug development expenses and the high failure rate of oncology drugs. The current ROI in drug development has been estimated to be as low as 0.3%. As experts try to reduce expenses and increase their chances of success, the industry is witnessing an increased emphasis on early decision making, adaptive programme design and strategic clinical alliances.

Over the 2 days, the Oncology Clinical Development Congress will provide a high-level platform for discussing these challenges and hearing case studies from those who have taken great steps in overcoming them. The conference programme consists of 20 world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive forum for scientific and business debate.

Over the two days, key opinion leaders will explore pioneering solutions and critical opportunities in areas such as targeted therapeutics, clinical imaging and operations management. On Day 1, our internationally recognised experts will discuss strategies for co-developing combined therapies, establishing clear endpoints and building successful clinical partnerships. On Day 2, delegates will hear from those working at the forefront of trial design, patient selection and clinical outsourcing.

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Gene Therapy Going Global with Portable Device
Portable 'gene therapy in a box' could make future cancer and HIV cures affordable in developing countries.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Wrapping up the Genome
Researchers successfully package complete yeast genome using purified components, yielding new insights into genome mechanisms.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Precision Medicine Guiding Cancer Patients’ Chemotherapy Decision
New study finds doctors use genetic test to measure breast cancer recurrence risk, make tailored treatment recommendations.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos